Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

A Non-Specific Resistance Factor in the Albumin Residue Revealed By the Serial Cephalin Flocculation Curve

Abstract

IN the last laboratory meeting of the Royal Society of Tropical Medicine, I demonstrated the various types of serial cephalin flocculation curves as obtained in health and disease with a special reference to their application in tropical derangements. In obtaining the curves, the serial dilution method was followed1, using ten tubes instead of Hanger's original one-tube method2. Serial cephalin flocculation curve I, shown in the accompanying figure, represents the normal range in fifty healthy volunteers. In a study of the mechanism of Hanger's test, which is comparable to the first tube in the serial dilution method, Kabat, Hanger et al.3 found the flocculating factor to be associated with the γ globulin. They failed, however, to find an inhibiting fraction in the albumins. Moore, Pierson et al.4 two years later, reported from the same laboratory the presence of an inhibiting fraction associated with the albumins. It is to be noted that these workers were using electrophoresis by means of which albumins appear homogeneous5. Dennis and Makari6, using salting-out methods, found the greatest concentrations of this inhibiting factor in the albumin residue. Since this inhibiting factor was found by the latter workers to be originally present in the serum in smaller amounts than the flocculating factor, the critical dilution-level of 0-04 mgm. is reached much earlier in the case of the inhibiting factor. The first zone representing the first five tubes in the figure presents, therefore, a delicate balance between flocculating factor (γ globulin) and inhibiting factor (albumin residue). In the second zone only the former is at work. This delicgite balance in this first zone represents as well a balance between the liver and reticulo-endothelial system.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Makari, J. G., J. Trap. Med. and Hyg., 49, 113 (1946).

    CAS  Google Scholar 

  2. Hanger, F. M., Trans. Assoc. Amer. Phys., 53, 148 (1938).

    Google Scholar 

  3. Kabat, E. A., Hanger, F. M., Moore, D. H., and Landow, H., J. Clin. Invest., 22, 563 (1943).

    Article  CAS  Google Scholar 

  4. Moore, D. B., Pierson, P. S., Hanger, F. M., and Moore, D. H., J. Clin Invest., 24, 292(1945).

    Article  CAS  Google Scholar 

  5. Cohn, E. J., Oneley, J. L., Strong, L. E., Armstrong, S. H., and Hughes, W. L., Jr., J. Clin. Invest., 23, 417 (1944).

    Article  CAS  Google Scholar 

  6. Dennis, E. W., and Makari, J. G., in the press.

  7. Makari, J. G., J. Trop. Med. and Hyg., 49, 70 (1946).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

MAKARI, J. A Non-Specific Resistance Factor in the Albumin Residue Revealed By the Serial Cephalin Flocculation Curve. Nature 160, 201–203 (1947). https://doi.org/10.1038/160201a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/160201a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing